| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | 10%+ Owner | Common Stock | 4,202,670 | $67,242,720 | $16.00 | 01 Jul 2024 | Indirect |
| PARDES BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 13,583,762 | $20,375,643 | $1.50 | 05 Apr 2023 | Indirect |
| Theseus Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1,385,825 | $4,226,766 | $3.05 | 17 Jul 2023 | Indirect |
| ALUMIS INC. | 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | 01 Jul 2024 | Indirect | ||
| ALUMIS INC. | 10%+ Owner | Series B-1 Redeemable Convertible Preferred Stock | 0 | 01 Jul 2024 | Indirect | ||
| ALUMIS INC. | 10%+ Owner | Series B-2 Redeemable Convertible Preferred Stock | 0 | 01 Jul 2024 | Indirect | ||
| ALUMIS INC. | 10%+ Owner | Series C Redeemable Convertible Preferred Stock | 0 | 01 Jul 2024 | Indirect | ||
| ALUMIS INC. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 01 Jul 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | 01 Jul 2024 | 32 | +$40,000,000 | 4 | 10%+ Owner | 03 Jul 2024, 21:30 |
| ALMS | ALUMIS INC. | 27 Jun 2024 | 0 | $0 | 3 | 10%+ Owner | 27 Jun 2024, 21:30 |
| /report/000120919123042720-foresite-capital-management-v-llc-2023-07-17 | Theseus Pharmaceuticals, Inc. | 17 Jul 2023 | 2 | +$2,079,000 | 4 | 10%+ Owner | 19 Jul 2023, 14:54 |
| /report/000121390023028116-foresite-capital-management-v-llc-2023-04-05 | PARDES BIOSCIENCES, INC. | 05 Apr 2023 | 1 | +$1,160,928 | 4 | 10%+ Owner | 06 Apr 2023, 21:08 |
| /report/000120919123000204-foresite-capital-management-v-llc-2022-12-29 | Theseus Pharmaceuticals, Inc. | 29 Dec 2022 | 2 | +$2,500,000 | 4 | 10%+ Owner | 03 Jan 2023, 15:24 |
| /report/000121390022077637-foresite-capital-management-v-llc-2022-12-01 | PARDES BIOSCIENCES, INC. | 01 Dec 2022 | 1 | +$541,807 | 4 | 10%+ Owner | 05 Dec 2022, 15:24 |
| /report/000120919122036392-foresite-capital-management-v-llc-2022-06-09 | Theseus Pharmaceuticals, Inc. | 09 Jun 2022 | 0 | $0 | 3 | 10%+ Owner | 13 Jun 2022, 17:15 |